În afara temei aiqbench
Această știre a fost preluată de la o sursă pe care o urmărim, dar nu ține de domeniul AI sau cuantic, așa că nu există o perspectivă aiqbench pentru ea.
Baiyunshan Receives Drug Registration Certificate for Irbesartan and Hydrochlorothiazide Tablets
36Kr reports that Baiyunshan announced its subsidiary, Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. (Tianxin Pharmaceutical), has received the 'Drug Registration Certificate' for Irbesartan and Hydrochlorothiazide Tablets, approved and issued by the National Medical Products Administration.
Citește articolul complet pe 36KrSubiecte conexe
Buchang Pharmaceutical: Company Receives Drug Registration Certificate for Tomoxetine Hydrochloride Oral Solution
36Kr · 9 oct. 2026
Tianen Kang: Receives Drug Registration Certificate for Polidocanol Injection
36Kr · 16 oct. 2026
TianenKang: Wholly-owned Subsidiary Receives Drug Registration Certificate for Diquafosol Ophthalmic Solution
36Kr · 9 oct. 2026
Daren Tang: Branch Receives Drug Registration Certificate for Loxoprofen Sodium Patch
36Kr · 9 oct. 2026